NET-Smart Chemotherapy: A Targeted Prodrug Strategy
Researcher: Justin Annes, MD, PhD Location: Stanford University Cancer Center State: California Year: 2018 Status: Active Grant Duration: 1 year Award: Pilot Award
Leave it blank
By taking advantage of unique properties of NETs that are not found in healthy cells, researchers will try to target chemotherapy to attack only cancer cells, instead of all cells. Creating novel chemotherapeutic agents that will attack and kill only NET cells, will help reduce the side effects of currently used systemic chemotherapy.
NET Research Foundation
321 Columbus Avenue, Suite 5R
Boston MA 02116